Community/Retail

Pharmacists can play a crucial role in promoting the flu vaccine to these patients by recognizing the characteristics of those who do not seek vaccinations.

Pharmacists play an important role in counseling patients on biologics.

A recently-released video from the CDC provides a great way to discuss vaccines with parents.

Pharmacists' increasing role in providing patient education and contact.

Officials with the FDA have approved enasidenib (Idhifa, Celgene Corporation) to treat adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation, isocitrate dehydrogenase-2 (IDH2), according to a FDA press release.

Is it time to change the type 2 diabetes treatment paradigm?

Offspring of pollutant-exposed ancestors also showed elevated levels of interleukin proteins that are involved in regulating the immune system, which are a marker of asthma risk.

Charlie Le Bon, the Director of Pharmacy Ownership for AmerisourceBergen, discusses recent changs in the pharmacy landscape.

The next time you see a bucket of chicken, I hope you reminds you my absolute favorite pneumonic device and how you can begin to work towards any goal you set out to achieve. Fortunately, this acronym is easy to remember and seen all over the world with signs of a global food franchise: Kentucky Fried Chicken, otherwise known as KFC.

The FDA has issued a safety alert after receiving serious adverse events reports regarding intravitreal (eye) injections of a medication containing triamcinolone and moxifloxacin.

Cardinal Health has completed the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency business for $6.1 billion.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

A vast buyer network can assist with purchasing community pharmacies.

Tennessee drug company Crown Laboratories Inc. has agreed to cease the manufacturing and distribution of unapproved and misbranded dermatologic creams and lotions.

A Mississippi pharmacist in charge of a compounding pharmacy pleaded guilty to his role in a $192 million compounded medication scheme, according to the Department of Justice (DOJ).

Pharmacists continue to rank among best-paying professions, but competition in the job market is high.

An FDA panel voted against recommending Intellipharmaceutics’ Rexista abuse-deterrent oxycodone hydrochloride extended release tablets, according to a company press release.

To help reduce the risk of injury from slips and falls, and to educate seniors in its communities, Walgreens will offer injury prevention tips and advice when it hosts a Senior Day at its stores nationwide on Tuesday, August 1.

CVS Health has announced that the opioid overdose-reversal medication naloxone is now available without an individual prescription at all CVS Pharmacy locations in South Dakota.

Many individuals develop a rash from poison ivy, oak, or sumac from the oil found in the sap of these poisonous plants.

In an evolving and technology-driven world, mobile text messaging is a feasible electronic option to improve adherence, as more people from all socioeconomic classes and age groups are using this technology

Pharmacists have become champions of influenza immunization, advertising heavily, recruiting patients, and administering these life-saving vaccines in a wide array of settings.

Many individuals who have end-stage renal disease (ESRD) fail to receive the vaccinations that they need.

Proposed cuts to the Medicare payment rates for drugs that hospitals acquire under the 340B Drug Pricing Program, if enacted, could have devastating consequences for the low-income and uninsured patients that receive care from the nation’s safety net hospitals, according to pharmacy group ASHP.

Resistance poses a global threat.

Officials with the FDA are requesting a new clinical study before Eli Lilly and Incyte Corporation can resubmit for a new drug application (NDA) for baricitinib, a once-daily oral medication for moderate-to-severe rheumatoid arthritis treatment.